MDVN and JNJ Related Headlines

Feb 28, 2013 03:47PM Medivation (MDVN) Reverses after Cowen Research Called into Question by Janney
Sep 19, 2012 10:22AM Wedbush Prostate Cancer Survey Reveals JNJ’s (JNJ) Zytiga has Still-Solid Market Position but Medivation’s (MDVN) Xtandi in Good Position at Launch
Sep 4, 2012 01:55PM Wedbush Reiterates an 'Outperform' on Medivation (MDVN); Raising PT on Early Approval
Sep 4, 2012 10:51AM Leerink Swann Maintains an 'Outperform' on Medivation (MDVN); Number of Advantages Based on Labeling
Jul 30, 2012 03:15PM Maxim Upgrades Dendreon (DNDN) as the Street is 'Too Bearish' Ahead of Q2 Results
Jul 16, 2012 07:58AM Medivation (MDVN) Ripe for the Picking on Expected Enzalutamide Approval
Jun 4, 2012 12:03PM Credit Suisse Ups Price Target on Medivation (MDVN) from $115 to $122
Jun 4, 2012 09:37AM Brean Murray Carret & Co. Maintains a 'Buy' on Medivation (MDVN); Zytiga Data Better Than Expected
Jun 4, 2012 09:09AM Wedbush Reiterates an 'Outperform' on Medivation (MDVN); Raising PT and 2013 Estimates

MDVN and JNJ Related Press Releases